LGMD2I
Clinical trials for LGMD2I explained in plain language.
Never miss a new study
Get alerted when new LGMD2I trials appear
Sign up with your email to follow new studies for LGMD2I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy trial opens for rare Muscle-Wasting condition
Disease control Recruiting nowThis study tests a single dose of a gene therapy called AB-1003 in 10 adults with limb girdle muscular dystrophy type 2I/R9, a genetic condition that weakens muscles. The main goal is to check safety and find the right dose. Participants must be able to walk 10 meters in under 30…
Matched conditions: LGMD2I
Phase: PHASE1, PHASE2 • Sponsor: AskBio Inc • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Researchers launch major study to better measure muscle disease progression
Knowledge-focused Recruiting nowThis 24-month study follows up to 1000 people with limb girdle muscular dystrophy, myotonic dystrophy type 2, or late-onset Pompe disease. Researchers will test simple physical tasks like walking and timed tests to see which measurements best track disease changes over time. The …
Matched conditions: LGMD2I
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated May 26, 2026 03:38 UTC